MondaySep 11, 2023 11:15 am

SuperCom Ltd. (NASDAQ: SPCB) Offers its Newest Solution for Increasing Public Safety, Reducing Domestic Violence, While Cutting Government Costs

SuperCom has introduced the all-in-one PureOne monitoring device with three unique tech modules, offering advanced technology for the cost-effective electronic home and civil monitoring of offenders The electronic offender monitoring market in Europe and the Americas is expected to reach $2.1 billion in 2026 and is seeking new technologies to meet a rapidly growing demand SuperCom’s innovative solutions promise a critical technological and social impact – improving public safety worldwide and reducing governmental costs in the process The company’s growth strategy includes potential acquisitions and expansion into new regions with limited electronic monitoring capabilities SuperCom (NASDAQ: SPCB), a leading global…

Continue Reading

MondaySep 11, 2023 9:45 am

RVL Pharmaceuticals plc (NASDAQ: RVLP) to Attend H.C. Wainwright 25th Annual Global Investment Conference and Discuss UPNEEQ(R) for Treating Acquired Blepharoptosis

RVL Pharmaceuticals' CEO Brian Markison and COO JD Schaub will participate in a fireside chat and 1-on-1 investor meetings on Tuesday, September 12, 2023, during this year's H.C. Wainwright Annual Global Investment Conference in New York City The company will discuss UPNEEQ(R) and its use as the first non-surgical treatment option approved by the FDA for acquired blepharoptosis RVL Pharmaceuticals plans to continue marketing to medical aesthetics providers and will launch a direct-to-consumer campaign later this year The medical aesthetics market was valued at $13.9 billion in 2022 and is expected to reach $23.4 billion by 2027 RVL Pharmaceuticals (NASDAQ:…

Continue Reading

MondaySep 11, 2023 9:00 am

Electronic Servitor Publication Network Inc. (XESP) Creating Digital Experiences that Elevate Customer Response

XESP continues to affirm its commitment to optimizing companies’ growth, mainly through its managed service that offers digital activation and engagement solutions Its proprietary technology, the Digital Engagement Engine(TM), which utilizes automation, unique data management, and a modern workflow, has proven to offer what no other competitor offers in the market This product is founded on critical principles integral to building customer loyalty, among them the importance of meeting customers’ demands for the modern digital experience Through this proprietary technology, XESP offers a solution that makes addressing the changing consumer demands a lot easier, faster, and more efficient Electronic Servitor…

Continue Reading

FridaySep 08, 2023 10:30 am

Lucy Scientific Discovery Inc. (NASDAQ: LSDI) Is ‘One to Watch’

In July 2023, LSDI launched Twilight, a new sleep aid product The company in July 2023 announced its acquisition of SANA-013 from Wesana Health; SANA-013 is being developed for the treatment of several mental health and central nervous system conditions LSDI in May 2023 launched its new Mindful product line designed to enhance well-being and promote a mindful approach to life Also in May 2023, the company announced a partnership with non-profit TheraPsil to advance medical psilocybin access and research LSDI announced in April 2023 that its board had approved the repurchase of up to 500,000 shares of its Class…

Continue Reading

FridaySep 08, 2023 9:45 am

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Looking Forward to Upcoming Interim Results for Potentially Pivotal GBM Study

CNS Pharmaceuticals recently announced updated results from its pivotal clinical study on GBM treatment through its lead drug candidate, Berubicin The novel anthracycline demonstrated its capability to be an innovative potential treatment option for GBM 151 patients have been enrolled in the study, marking the data cutoff point and a significant milestone toward reporting topline results before the end of the year Based on the results seen preclinically, the company remains optimistic that Berubicin may provide a much-needed clinical benefit for GBM patients CNS Pharmaceuticals (NASDAQ: CNSP), a clinical-stage biotechnology company specializing in the development of novel treatments with a…

Continue Reading

FridaySep 08, 2023 9:00 am

Longeveron Inc. (NASDAQ: LGVN) Is ‘One to Watch’

In June 2023, Longeveron filed with the SEC to offer subscription rights worth up to $30 million of shares of Class A common stock to stockholders and holders of warrants. The rights offering, which became effective on August 17, 2023, is being made through a distribution of five tradable subscription rights (listed on The NASDAQ Capital Market under the ticker symbol LGVNR) to purchase shares of Class A common stock for each share of common stock and warrant to purchase common stock owned as of the record date of August 18, 2023, at a $3.00 subscription price per share. The…

Continue Reading

ThursdaySep 07, 2023 10:30 am

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Demonstrates Power of REE Processing During US Embassy Staff Visit to Kingston Plant

Ucore Rare Metals Inc. is a supply chain innovator dedicated to establishing North American production of tech-critical rare earth elements (“REEs”), a resource currently dependent upon Chinese industry priorities and governmental policies Ucore recently hosted representatives from the U.S. Embassy in Canada for an exclusive tour of the company’s proprietary RapidSX(TM) REE processing demonstration facility in Ontario The tour underscores the importance of international collaboration in establishing a North American supply for REEs and the strategic importance of such a supply chain to varied national interests Ucore intends to begin construction later this year on a commercial-scale REE production facility…

Continue Reading

ThursdaySep 07, 2023 10:00 am

Appia Rare Earths & Uranium Corp. (CSE: API) (OTCQX: APAAF) Is ‘One to Watch’

A field project review in June 2023 confirmed widespread mineralization at Appia’s Ionic Clay Project in Brazil The company’s highly experienced management team has more than 100 years of combined experience in the metals and minerals industry Appia’s Alces Lake project contains some of the highest-grade total critical REE mineralization in the world As of June 2023, the company had no debt Appia Rare Earths & Uranium (CSE: API) (OTCQX: APAAF) is a mineral exploration company focused on exploration activities at its newly acquired Cachoeirinha rare earths project (“PCH Project”) in Brazil, as well as delineating high-grade critical rare earth…

Continue Reading

ThursdaySep 07, 2023 10:00 am

D-Wave Quantum Inc. (NYSE: QBTS) Announces Update to Constrained Quadratic Model Hybrid Solver

D-Wave introduced algorithmic updates to its Constrained Quadratic Model (“CQM”) solver, delivering increased performance for existing binary problem classes, including offer allocation, portfolio optimization, and satisfiability D-Wave tested 2,045 binary quadratic problems, with the new CQM solver winning 80% of the problems against prior versions D-Wave's hybrid solvers expand the size and complexity of potential problems customers can solve using classical and quantum computation to find better answers to complex business problems D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software, and services and the world's first commercial supplier of quantum computers, recently announced an update to its…

Continue Reading

ThursdaySep 07, 2023 9:30 am

The Strategic Brilliance of Acquiring High Times IP, Including Existing Licensing Agreements and Royalty Streams in All-Stock Transaction

Lucy Scientific Beats MindMed and Seelos Therapeutics to the Punch Lucy Scientific Discovery (NASDAQ: LSDI) (“Lucy” or the “Company), a Nasdaq-listed company with holdings and operations in a variety of psychotropic businesses, just announced the acquisition of the Intellectual Property of High Times, its Licensing Agreements and Royalty Streams in all-stock transaction. This was a brilliant strategic business move. With first movers in the “Mind Science” space like MindMed (NASDAQ: MNMD) and Seelos Therapeutics (NASDAQ: SEEL) realizing than 80% and 40% year-to-date gains respectively, today’s acquisition by Lucy delivers immediate revenue, an expanded product line, a proven and highly influential…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered